Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 10, 2022 02:00PM
|
Re: BOD AGM
|
6
|
Resverlogix Corp.
|
Jun 01, 2022 12:39PM
|
Level 2 Quotes this morning
|
4
|
Resverlogix Corp.
|
Jun 15, 2022 09:49AM
|
Re: Level 2 Quotes this morning
|
4
|
Resverlogix Corp.
|
Jun 18, 2022 10:11PM
|
Anonymous trader
|
2
|
Resverlogix Corp.
|
Jun 21, 2022 11:45AM
|
I expect a ho hum type of AGM today
|
2
|
Resverlogix Corp.
|
Jun 21, 2022 11:51AM
|
What if
|
2
|
Resverlogix Corp.
|
Jul 15, 2022 11:19AM
|
HOW LONG
|
4
|
Resverlogix Corp.
|
Jul 27, 2022 08:27AM
|
FDA meeting
|
3
|
Resverlogix Corp.
|
Aug 08, 2022 02:19PM
|
Re: USA ZHCLF investors
|
|
Zenith Epigenetics
|
Nov 01, 2022 08:31AM
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Nov 02, 2022 11:47AM
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 02, 2022 11:56AM
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 04, 2022 12:05PM
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 04, 2022 01:16PM
|
Apabetalone may be able to help
|
1
|
Resverlogix Corp.
|
Jan 01, 2023 03:52PM
|
Re: BARCHART OPINION - Overall Average 100% BUY
|
|
Zenith Epigenetics
|
Mar 08, 2023 04:10AM
|
Zenith Epigenetics Corp (ZEC) held the shares issued to RVX shareholders in June 2013.
|
2
|
Zenith Epigenetics
|
Apr 13, 2023 01:25PM
|
Voting you shares.
|
8
|
Resverlogix Corp.
|
Jun 05, 2023 08:03PM
|
Re: Voting you shares.
|
4
|
Resverlogix Corp.
|
Jun 21, 2023 05:49PM
|
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
2
|
Zenith Epigenetics
|
May 19, 2024 08:42AM
|